Han Lin, a member of the Standing Committee of the Party Committee of the Binhai High-tech Zone and Deputy Director of the Management Committee, led a team to visit and conduct research at Chuangyuan Biotechnology.

On November 9, 2022, Han Lin, a member of the Standing Committee of the Tianjin Binhai High-tech Zone Party Committee and Deputy Director of the Management Committee, along with Zhao Jing, Director of the Biopharmaceutical Industry Bureau of the High-tech Zone, conducted an in-depth visit and research.Tianjin Chuangyuan Biotechnology Co., Ltd.Chuangyuan Biotechnology was received by Dr. Liang Wu, Chairman of Chuangyuan Biotechnology, Fu Tianmin, President, Shi Yali, Executive Vice President, and Dr. Wang Haikuan, Vice President and Dean of Chuangyuan Health College.

At the symposium, Chairman Liang Wu first warmly welcomed Deputy Director Han Lin and his team, and provided a detailed introduction to the current development status, research planning, and strategic planning of Chuangyuan Biotechnology; President Fu Tianmin gave a serious report on the current brand partners andthe "Chuangyuan Biotechnology Phase II Production Base and Probiotics and Postbiotics Technology and Application Key Laboratory Project." After listening to the report, Deputy Director Han Lin made suggestions regarding the current cooperation between industry, academia, and research, innovation platform construction, and talent introduction and training, and highly affirmed the transformation of the company's core technological achievements and the construction of a pilot sharing platform, providing strong support. Deputy Director Han Lin emphasized that the government of the High-tech Zone always adheres to consulting enterprises for advice and needs, strengthening classified policies and precise support strategies, and will promptly help enterprises solve difficulties and problems, supporting them to grow and strengthen. At the same time, biomedicine is a key development area for technological innovation in the Binhai High-tech Zone, and as a key enterprise in the park, Chuangyuan Biotechnology should adhere to technology-driven innovation, accelerate the construction of high-level innovation platforms and talent training platforms, continue to deepen development in the field of biotechnology, and enhance the core competitiveness of the enterprise. Director Zhao Jing stated that the Biopharmaceutical Industry Bureau will actively support enterprise development in various aspects, including promoting channel integration and connecting with high-end experts from research institutions.

After the meeting, Deputy Director Han Lin and his team, accompanied by Chairman Liang Wu and the Chuangyuan executive team, visited the construction base of the Chuangyuan Biotechnology Phase II Production Base and the Probiotics andPostbiotics Technology and ApplicationKey Laboratory Project. Deputy Director Han Lin stated that the enterprise should accelerate the construction progress while ensuring safe production, and at the same time, various functional departments of the High-tech Zone government will actively support and cooperate to strive for the project to be completed and put into production as soon as possible, better, faster, and more to explore new fields and new tracks, continuously shaping new momentum and new advantages for development, driving the development and upgrading of the biotechnology industry, improving public health through biotechnology, and assisting the development of China's big health industry.

Chuangyuan Biotechnology, Postbiotics, Tianjin Chuangyuan Biotechnology Co., Ltd., Binhai High-tech Zone Government

Tianjin University of Science and Technology and Tianjin Chuangyuan Biotechnology Co., Ltd. jointly developed results have been granted a national invention patent.

The second phase of the production base of Chuangyuan Biotechnology and the key laboratory for micro-ecological preparations has reached its topping-out.

Tianjin University of Science and Technology and Tianjin Chuangyuan Biotechnology Co., Ltd. jointly developed results have been granted a national invention patent.

The second phase of the production base of Chuangyuan Biotechnology and the key laboratory for micro-ecological preparations has reached its topping-out.

2024-12-23

In December 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. and Haihe Dairy jointly held a series of themed activities titled "Party Building Mutual Visits and Learning" to further promote the deep integration of both parties' party building work and business development. During the event, both sides will conduct company visits and on-site discussions. Recently, Haihe Dairy made an initial visit and, after gaining a deep understanding of Chuangyuan Biotech's products, expressed high recognition and close attention, laying a solid foundation for future cooperation. Subsequently, both parties engaged in detailed communication on the core topics of "exchange of party building experiences and sharing of business resources," discussing standardized construction of party branches, distinctive party building measures, and the promotion of party-business integration. They also conducted in-depth exchanges on aspects such as corporate cooperation, product intercommunication, and information sharing, jointly exploring new paths for the development of the health industry under the guidance of party building, providing more possibilities for further establishing a "symbiotic, mutually promoting, and win-win" cooperative relationship. Both parties hope to achieve industrial resonance through party building leadership and contribute to the development of the health industry in the Binhai New Area.

Strength crowned, Chuangyuan Biotechnology won two Science and Technology Awards from the China Food Industry Association.

2024-12-17

On December 16, 2024, the 22nd China Food Safety Conference and the 2024 National Food Industry Science and Technology Progress Conference, themed "Implementing Food Safety Strategy to Support the Construction of a Healthy China," was grandly held in Beijing. During the conference, the award ceremony for the 2024 National Food Industry Science and Technology Progress Conference was also held. Tianjin Chuangyuan Biotechnology Co., Ltd. won the second prize for scientific and technological progress in the "2023 China Food Industry Association Science and Technology Award" for two projects: "Key Technology Breakthrough and Industrial Application of New Postbiotics Segmented Solid-State Fermentation" and "Development and Application of Key Technologies and Equipment for Plant Polysaccharide Efficacy Verification and Extraction."

Chuangyuan Biotech's lactic acid bacteria IOB701 post-fermentation probiotic powder has been granted a national invention patent.

2024-12-13

On December 13, 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. received an invention patent certificate from the National Intellectual Property Administration for its independently developed and filed method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder (Patent No.: ZL 202411354886.X). This invention provides a method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder, which relates to the field of microbiology. The Lactobacillus plantarum IOB701 was preserved on July 10, 2018, at the General Microbial Culture Collection Center of the China Microbial Strain Preservation Management Committee, abbreviated as CGMCC, with the preservation address at No. 3, Courtyard 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number CGMCC No. 16077. Using grains or legumes treated with low oxygen stress as the fermentation substrate, the Lactobacillus plantarum IOB701 fermentation resulted in postbiotics powder, which, according to animal experiments, has been shown to improve chronic unpredictable mild stress-induced depressive-like behavior in mice.

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Jin Gong Wang An Bei No. 12019202000539

Business License